Fei Shen, MD
Assistant Scientist in Medicine
- Address
-
R3 246
MDEP
IN
, IN - PubMed:
-
Link to PubMed
| Year | Degree | Institution |
|---|---|---|
| 1995 | MD | University of Lausanne |
| 1984 | BMED | Xi'an Medical University |
Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells.
Cantor EL; Shen F; Jiang G; Tan Z; Cunningham GM; Wu X; Philips S; Schneider BP; Scientific reports 2022 Sep 23
Cantor EL; Shen F; Jiang G; Tan Z; Cunningham GM; Wu X; Philips S; Schneider BP; Scientific reports 2022 Sep 23
A non-coding GWAS variant impacts anthracycline-induced cardiotoxic phenotypes in human iPSC-derived cardiomyocytes.
Wu X; Shen F; Jiang G; Xue G; Philips S; Gardner L; Cunningham G; Bales C; Cantor E; Schneider BP; Nature communications 2022 Nov 22
Wu X; Shen F; Jiang G; Xue G; Philips S; Gardner L; Cunningham G; Bales C; Cantor E; Schneider BP; Nature communications 2022 Nov 22
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Quintanilha JCF; Wang J; Sibley AB; Jiang C; Etheridge AS; Shen F; Jiang G; Mulkey F; Patel JN; Hertz DL; Dees EC; McLeod HL; Bertagnolli M; Rugo H; Kindler HL; Kelly WK; Ratain MJ; Kroetz DL; Owzar K; Schneider BP; Lin D; Innocenti F; British journal of cancer 2021 Oct 6
Quintanilha JCF; Wang J; Sibley AB; Jiang C; Etheridge AS; Shen F; Jiang G; Mulkey F; Patel JN; Hertz DL; Dees EC; McLeod HL; Bertagnolli M; Rugo H; Kindler HL; Kelly WK; Ratain MJ; Kroetz DL; Owzar K; Schneider BP; Lin D; Innocenti F; British journal of cancer 2021 Oct 6
Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity.
Scott EN; Wright GEB; Drögemöller BI; Hasbullah JS; Gunaretnam EP; Miao F; Bhavsar AP; Shen F; Schneider BP; Carleton BC; Ross CJD; NPJ genomic medicine 2021 May 21
Scott EN; Wright GEB; Drögemöller BI; Hasbullah JS; Gunaretnam EP; Miao F; Bhavsar AP; Shen F; Schneider BP; Carleton BC; Ross CJD; NPJ genomic medicine 2021 May 21
Analytical Validation of Variants to Aid in Genotype-Guided Therapy for Oncology.
Swart M; Stansberry WM; Pratt VM; Medeiros EB; Kiel PJ; Shen F; Schneider BP; Skaar TC; The Journal of molecular diagnostics : JMD 2019 Feb 20
Swart M; Stansberry WM; Pratt VM; Medeiros EB; Kiel PJ; Shen F; Schneider BP; Skaar TC; The Journal of molecular diagnostics : JMD 2019 Feb 20
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Tolaney SM; Guo H; Pernas S; Barry WT; Dillon DA; Ritterhouse L; Schneider BP; Shen F; Fuhrman K; Baltay M; Dang CT; Yardley DA; Moy B; Marcom PK; Albain KS; Rugo HS; Ellis MJ; Shapira I; Wolff AC; Carey LA; Overmoyer B; Partridge AH; Hudis CA; Krop IE; Burstein HJ; Winer EP; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Apr 2
Tolaney SM; Guo H; Pernas S; Barry WT; Dillon DA; Ritterhouse L; Schneider BP; Shen F; Fuhrman K; Baltay M; Dang CT; Yardley DA; Moy B; Marcom PK; Albain KS; Rugo HS; Ellis MJ; Shapira I; Wolff AC; Carey LA; Overmoyer B; Partridge AH; Hudis CA; Krop IE; Burstein HJ; Winer EP; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Apr 2
Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).
Li M; Mulkey F; Jiang C; O'Neil BH; Schneider BP; Shen F; Friedman PN; Momozawa Y; Kubo M; Niedzwiecki D; Hochster HS; Lenz HJ; Atkins JN; Rugo HS; Halabi S; Kelly WK; McLeod HL; Innocenti F; Ratain MJ; Venook AP; Owzar K; Kroetz DL; Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Jun 5
Li M; Mulkey F; Jiang C; O'Neil BH; Schneider BP; Shen F; Friedman PN; Momozawa Y; Kubo M; Niedzwiecki D; Hochster HS; Lenz HJ; Atkins JN; Rugo HS; Halabi S; Kelly WK; McLeod HL; Innocenti F; Ratain MJ; Venook AP; Owzar K; Kroetz DL; Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Jun 5
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.
Schneider BP; Li L; Shen F; Miller KD; Radovich M; O'Neill A; Gray RJ; Lane D; Flockhart DA; Jiang G; Wang Z; Lai D; Koller D; Pratt JH; Dang CT; Northfelt D; Perez EA; Shenkier T; Cobleigh M; Smith ML; Railey E; Partridge A; Gralow J; Sparano J; Davidson NE; Foroud T; Sledge GW; British journal of cancer 2014 Aug 12
Schneider BP; Li L; Shen F; Miller KD; Radovich M; O'Neill A; Gray RJ; Lane D; Flockhart DA; Jiang G; Wang Z; Lai D; Koller D; Pratt JH; Dang CT; Northfelt D; Perez EA; Shenkier T; Cobleigh M; Smith ML; Railey E; Partridge A; Gralow J; Sparano J; Davidson NE; Foroud T; Sledge GW; British journal of cancer 2014 Aug 12
Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial.
Schneider BP; Gray RJ; Radovich M; Shen F; Vance G; Li L; Jiang G; Miller KD; Gralow JR; Dickler MN; Cobleigh MA; Perez EA; Shenkier TN; Vang Nielsen K; Müller S; Thor A; Sledge GW Jr; Sparano JA; Davidson NE; Badve SS; Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jan 22
Schneider BP; Gray RJ; Radovich M; Shen F; Vance G; Li L; Jiang G; Miller KD; Gralow JR; Dickler MN; Cobleigh MA; Perez EA; Shenkier TN; Vang Nielsen K; Müller S; Thor A; Sledge GW Jr; Sparano JA; Davidson NE; Badve SS; Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jan 22
Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment.
Schneider BP; Shen F; Miller KD; The Lancet. Oncology 2012 Oct
Schneider BP; Shen F; Miller KD; The Lancet. Oncology 2012 Oct
Phosphorylation: the molecular switch of double-strand break repair.
Summers KC; Shen F; Sierra Potchanant EA; Phipps EA; Hickey RJ; Malkas LH; International journal of proteomics 2011 May 18
Summers KC; Shen F; Sierra Potchanant EA; Phipps EA; Hickey RJ; Malkas LH; International journal of proteomics 2011 May 18
Nuclear protein isoforms: implications for cancer diagnosis and therapy.
Shen F; Kirmani KZ; Xiao Z; Thirlby BH; Hickey RJ; Malkas LH; Journal of cellular biochemistry 2011 Mar
Shen F; Kirmani KZ; Xiao Z; Thirlby BH; Hickey RJ; Malkas LH; Journal of cellular biochemistry 2011 Mar
Dynamic assessment of mitoxantrone resistance and modulation of multidrug resistance by valspodar (PSC833) in multidrug resistance human cancer cells.
Shen F; Bailey BJ; Chu S; Bence AK; Xue X; Erickson P; Safa AR; Beck WT; Erickson LC; The Journal of pharmacology and experimental therapeutics 2009 May 7
Shen F; Bailey BJ; Chu S; Bence AK; Xue X; Erickson P; Safa AR; Beck WT; Erickson LC; The Journal of pharmacology and experimental therapeutics 2009 May 7
Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells.
Shen F; Chu S; Bence AK; Bailey B; Xue X; Erickson PA; Montrose MH; Beck WT; Erickson LC; The Journal of pharmacology and experimental therapeutics 2007 Oct 18
Shen F; Chu S; Bence AK; Bailey B; Xue X; Erickson PA; Montrose MH; Beck WT; Erickson LC; The Journal of pharmacology and experimental therapeutics 2007 Oct 18
Is erythrocyte alkaline phosphatase activity a marker of zinc status in humans?
Samman S; Soto C; Cooke L; Ahmad Z; Farmakalidis E; Biological trace element research 1996 Mar
Samman S; Soto C; Cooke L; Ahmad Z; Farmakalidis E; Biological trace element research 1996 Mar
Looking for patient care?
To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.